business · City PM ↗
Pfizer offers competition remedy
Citation-ready fact
Pfizer's planned takeover of Wyeth is valued at $68 billion (£41 billion).
68 billion USD · takeover value41 billion GBP · takeover value
European Commission, Commission
Citation-ready fact
The European Commission extended the deadline for its review of the Pfizer‑Wyeth deal to 20 July, moving it back from 6 July.
European Commission, Commission
Citation-ready fact
The European Commission stated that Pfizer's $68 billion (£41 billion) planned takeover of rival Wyeth may be anti-competitive.
68 USD · takeover41 GBP · takeover
European Commission
US drugmaker Pfizer has offered remedies aimed at tackling concerns that its $68bn (£41bn) planned takeover of rival Wyeth may be anti-competitive, the European Commission said yesterday. The Commission, which polices competition in the 27-country European Union, said in a daily list of planned mergers under scrutiny that it had extended the deadline for its review of the deal to 20 July from 6 July.
This article was originally published by City PM ↗. citations.press indexes the source-backed facts above and links to the original. Something wrong? Corrections policy · Report an error